Table 5.
Incidence of parkinsonian events (SAS)
| AE | PLA-DON10 | DON5-DON10 | DON10-DON10 | DON-DON10 a |
|---|---|---|---|---|
| ( n =37) | ( n =47) | ( n =49) | ( n =96) | |
| Subjects with any parkinsonian events, n (%) | 5 (13.5) | 3 (6.4) | 9 (18.4) | 12 (12.5) |
| Camptocormia | 0 | 0 | 1 (2.0) | 1 (1.0) |
| Akinesia | 1 (2.7) | 0 | 0 | 0 |
| Parkinsonism | 3 (8.1) | 3 (6.4) | 9 (18.4) | 12 (12.5) |
| Tremor | 1 (2.7) | 0 | 0 | 0 |
SAS, safety analysis set; AE, adverse event.
aDON5-DON10 and DON10-DON10 groups.